The MagnaSafe Registry, a new multicenter study led by scientists at The Scripps Research Institute (TSRI), has demonstrated that appropriately screened and monitored patients with standard or non-MRI-conditional pacemakers and defibrillators can...
22-Feb-2017 7:05 PM EST Add to Favorites
TSRI-Invented Compound Ozanimod Shows Positive Results in Late-Stage Clinical Trial for Relapsing Multiple Sclerosis
Results from a new Phase 3 study conducted by the Celgene Corporation demonstrate that ozanimod, a drug candidate originally discovered and optimized at The Scripps Research Institute (TSRI), can reduce the frequency of multiple sclerosis relapse.
21-Feb-2017 12:05 PM EST Add to Favorites
In a study recently published online in the journal Molecular Metabolism, Chakraborty and his colleagues have shown that deleting the gene for this protein, known as IP6K1, protects animal models from both obesity and diabetes.
15-Feb-2017 12:05 PM EST Add to Favorites
Scripps Florida Collaboration Awarded $3.3 Million to Develop Next-Generation Breast Cancer Therapies
A pair of scientists from the Florida campus of The Scripps Research Institute (TSRI) have been awarded up to $3.3 million from the National Cancer Institute of the National Institutes of Health (NIH) to create the next generation of breast cancer...
14-Feb-2017 11:05 AM EST Add to Favorites
In a new study, researchers at The Scripps Research Institute (TSRI) have described how two important molecules in the brain work together to trigger intense anxiety.
13-Feb-2017 12:05 PM EST Add to Favorites
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered the details behind the virus’s unique ability to cross the placental barrier and expose the fetus to a range of birth defects that often go beyond...
6-Feb-2017 3:05 PM EST Add to Favorites
Chemists at The Scripps Research Institute (TSRI) have invented a new technique for constructing chiral drug molecules.
2-Feb-2017 2:05 PM EST Add to Favorites
Scientists at The Scripps Research Institute (TSRI) have found that deep brain stimulation (DBS) can greatly reduce the compulsion to use heroin in standard rat models of addiction.
1-Feb-2017 2:05 PM EST Add to Favorites
12-Sep-2016 3:05 PM EDT
7-Mar-2016 4:05 PM EST
29-Jan-2016 1:05 PM EST
9-Oct-2014 1:00 PM EDT
1-Aug-2014 12:00 PM EDT
6-May-2014 8:00 PM EDT
25-Mar-2014 1:00 PM EDT